L-arginine and aged garlic extract for the prevention of migraine: a study protocol for a randomised, double-blind, placebo-controlled, phase-II trial (LARGE trial)

被引：0
作者：
Devahuti R. Chaliha
Mauro Vaccarezza
Emily Corti
Ryusuke Takechi
Satvinder S. Dhaliwal
Peter Drummond
Eric Visser
Fred K. Chen
Jason Charng
Virginie Lam
John C.L. Mamo
机构：
[1] Curtin University,Curtin Health Innovation Research Institute, Faculty of Health Sciences
[2] Curtin University,School of Population Health, Faculty of Health Sciences
[3] Curtin University,Curtin Medical School, Faculty of Health Sciences
[4] National University of Singapore,Duke
[5] Universiti Sains Malaysia,NUS Medical School
[6] Singapore University of Social Sciences,Institute for Research in Molecular Medicine (INFORMM)
[7] Murdoch University,College of Science, Health, Engineering and Education (SHEE)
[8] University of Notre Dame,School of Medicine
[9] The University of Western Australia,Centre for Ophthalmology and Visual Science (incorporating Lions Eye Institute)
[10] The University of Melbourne,Ophthalmology, Department of Surgery
[11] The University of Western Australia,Department of Optometry, School of Allied Health
来源：
BMC Neurology | / 23卷
关键词：
Aged garlic extract; L-arginine; Chronic frequent episodic migraine; Photosensitivity; Randomised controlled trial; Retinal imaging; Vascular tone.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 198 条
[1]  
Andlin-Sobocki P(2005)Cost of disorders of the brain in Europe Eur J Neurol 12 1-27
[2]  
Jönsson B(2005)The global burden of migraine: measuring disability in headache disorders with WHO’s classification of Functioning, disability and health (ICF) J Headache Pain 6 429-43
[3]  
Wittchen H-U(2003)Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment Headache: The Journal of Head and Face Pain 43 36-76
[4]  
Olesen J(2019)Patient selection for migraine preventive treatment with anti-CGRP (r) monoclonal antibodies Expert Rev Neurother 19 769-57
[5]  
Leonardi M(2018)Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: results from the US societal and payer perspectives Cephalalgia 38 1644-7
[6]  
Steiner TJ(2016)Risk of medication overuse headache across classes of treatments for acute migraine J Headache Pain 17 107-88
[7]  
Scher AT(2009)Overuse of acute migraine medications and migraine chronification Curr Pain Headache Rep 13 301-88
[8]  
Lipton RB(2001)Current options for the prevention and treatment of migraine Clin Ther 23 772-74
[9]  
Gallagher RM(2016)Wiping out CGRP: potential cardiovascular risks Trends Pharmacol Sci 37 779-53
[10]  
Kunkel R(2019)Targeting calcitonin gene-related peptide: a new era in migraine therapy The Lancet 394 1765-97
12345678910